Contract Notice Detail

Summary Information

Summary Information
2,041.600000 Euro
 
1720124 
Irinotecano 500 mg/25 ml Sol inj Fr 25 ml IV CPA 2023/491 Rutura 
Tendering Phase
Awarded
1720124 Irinotecano 500 mg/25 ml Sol inj Fr 25 ml IV CPA 2023/491 Rutura 
VortalGOV - Acquisition under a Framework Agreement (via Direct Award) 
Lot NameLot Base PriceExpected Duration
I950 - IRINOTECANO [500 MG/25 ML; CONC P/A SOL P/A PERFUSÃO; FRS]-30 (Days)

Object of the Contract

Object of the Contract
Supplies Acquisition 
Rua Conceição Fernandes 4434-502 Vilar de Andorinho Vila Nova de Gaia Área Metropolitana do Porto PORTUGAL  
33600000-6 - Pharmaceutical products
 
 
 

Scheduling

Scheduling
8/27/2024 1:59 PM (UTC +1 hour)
 
9/4/2023 1:56 PM (UTC +1 hour)
 
8/28/2024 12:00 PM (UTC +1 hour)
 

Financial Settings

Financial Settings
No 

Contract Documents

Contract Documents
Document NameDescriptionDoc Classification
Convite SPMS.pdfConvite SPMS.pdfDownload

Object of contract

No 
No 

Legal, economic, financial and technical information

No 

Questionnaire

Questionnaire
1
Lot Title
I950 - IRINOTECANO [500 MG/25 ML; CONC P/A SOL P/A PERFUSÃO; FRS]
Base Price
2 041,600000

1.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
116804204 IRINOTECANO [500 MG/25 ML; CONC P/A SOL P/A PERFUSÃO; FRS] 80,000000 PT1.UMT.4520
Buyer Comment: 502266791 | Hikma Farmacêutica, S.A. | CPA:2023491/62/0251 | NºAIM:5484902; 504293753 | Fresenius Kabi Pharma Portugal, Lda. | CPA:2023491/51/0468 | NºAIM:5371067; 508107997 | Generis Farmacêutica, S.A. | CPA:2023491/263/0189 | NºAIM:5189865; 508622263 | Accord Healthcare, Unipessoal, Lda. | CPA:2023491/528/0576 | NºAIM:5734165;
TOTAL (The amounts shown do not include VAT)

Evaluation

Evaluation
Vision undefinedundefined

Public Messages

Public Messages
TypeReferenceSubjectDate
No items found...